Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT01142427

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

View all 244 locations

View Trial Details

Completed

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT02767388

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

NCT00081809

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

NCT00003838

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Allo HSCT Using RIC for Hematological Diseases

NCT02661035

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, B-cell Lymphoma, +59 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07

NCT02049515

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: La Jolla, California, United States

Denver, Colorado, United States

Fort Myers, Florida, United States

St. Petersburg, Florida, United States

View all 69 locations

View Trial Details

Completed

Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

NCT02122081

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +27 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)

NCT02004522

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: La Jolla, California, United States

Denver, Colorado, United States

Altamonte Springs, Florida, United States

Bonita Springs, Florida, United States

View all 92 locations

View Trial Details

Completed

Reducing Fasting Time in Children for Sedation

NCT05757882

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Jinyoung Song Seoul, Gangnam, South Korea

View Trial Details

Completed

Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia

NCT02336282

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions